Revista Alergia México (Apr 2019)

MASK (Mobile Airways Sentinel Network). ARIA’s comprehensive solution for mobile app for the multimorbidity of allergic rhinitis and asthma

  • Désirée Larenas-Linnemann,
  • Joaquim Mullol,
  • Juan Carlos Ivancevich,
  • Josep Antó,
  • Victoria Cardona,
  • Toni Dedeu,
  • Mónica Rodríguez-González,
  • Yunuen Huerta,
  • Hugo Neffen,
  • José Miguel Fuentes-Pérez,
  • Eréndira Rodríguez-Zagal,
  • Antonio Valero,
  • Mario Zernotti,
  • Joan Bartra,
  • Isam Alobid,
  • José Antonio Castillo-Vizuete,
  • Teresa Dordal,
  • Rafael Hijano,
  • César Picado,
  • Joaquín Sastre,
  • Ariel Eduardo Blua,
  • Edgardo Jares,
  • Alberto Jorge Lavrut,
  • Jorge Máspero,
  • Martín Bedolla-Barajas,
  • María Burguete,
  • María del Carmen Costa,
  • Margarita Domínguez-Silva,
  • Jesús Guillermo Espinoza-Contreras,
  • José Luis Gálvez-Romero,
  • Cecilia Yvonne García-Cobas,
  • María de la Luz Hortensia García-Cruz,
  • Luiana Hernández-Velázquez,
  • Jorge Luna-Pech,
  • Juan José Matta,
  • María Dolores Mogica-Martínez,
  • Daniela Rivero-Yeverino,
  • Lucy Tania Ruiz-Segura,
  • Blanca Del Río-Navarro,
  • Javier Gómez,
  • Alejandra Macías-Weinmann,
  • Ruth Murray,
  • Gabrielle Onorato,
  • Daniel Laune,
  • Anna Bedbrook,
  • Jean Bousquet

DOI
https://doi.org/10.29262/ram.v66i1.578
Journal volume & issue
Vol. 66, no. 1
pp. 140 – 146

Abstract

Read online

The vast majority of patients with allergic rhinitis (AR) do not receive the proper management which is recommended by the guidelines, but they frequently self-medicate. MASK (Mobile Airways Sentinel Network) is an integral part of a project that is supported by the European Union against chronic diseases and focused on active and healthy aging. MASK represents the third phase of ARIA (Allergic Rhinitis and its Impact on Asthma), in which, by using a mobile application in a smart device, the objective is to guide the patient in the control of his/her multi-morbidity, AR and/or allergic conjunctivitis (AC) and/or asthma. The mobile app Allergy Diary by MACVIA-ARIA is free and it is available for both Android and iOS platforms. After it is downloaded to the patient’s cell phone, it first requests some information about the patient’s profile, allergic pathologies and medication; afterwards, through a visual analog scale, the patient is invited to determine the degree of affectation in the nose, eyes, and bronchi, and its influence on their productivity at work / school. After analyzing the data generated by filling the Allergy Diary, it became clear there is a new clinical entity: allergic rhinitis+ allergic conjunctivitis +asthma, with greater effect; in addition to a high level of self-medication: in general, the patient takes medication on days when symptoms are present. The app has already been deployed in 23 countries, including several Spanish-speaking countries.

Keywords